Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M411482200 on October 19, 2004

J. Biol. Chem., Vol. 279, Issue 52, 54275-54282, December 24, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/52/54275    most recent
M411482200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mahrus, S.
Right arrow Articles by Craik, C. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mahrus, S.
Right arrow Articles by Craik, C. S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Granzyme M Is a Regulatory Protease That Inactivates Proteinase Inhibitor 9, an Endogenous Inhibitor of Granzyme B*

Sami Mahrus{ddagger}, Walter Kisiel§, and Charles S. Craik{ddagger}¶||

From the {ddagger}Chemistry and Chemical Biology Graduate Program, University of California, San Francisco, California 94143-2280, the §Department of Pathology, University of New Mexico Health Sciences Center, Albuquerque, New Mexico 87131-5301, and the Department of Pharmaceutical Chemistry, University of California, San Francisco, California 94143-2280

Granzyme M is a trypsin-fold serine protease that is specifically found in the granules of natural killer cells. This enzyme has been implicated recently in the induction of target cell death by cytotoxic lymphocytes, but unlike granzymes A and B, the molecular mechanism of action of granzyme M is unknown. We have characterized the extended substrate specificity of human granzyme M by using purified recombinant enzyme, several positional scanning libraries of coumarin substrates, and a panel of individual p-nitroanilide and coumarin substrates. In contrast to previous studies conducted using thiobenzyl ester substrates (Smyth, M. J., O'Connor, M. D., Trapani, J. A., Kershaw, M. H., and Brinkworth, R. I. (1996) J. Immunol. 156, 4174–4181), a strong preference for leucine at P1 over methionine was demonstrated. The extended substrate specificity was determined to be lysine = norleucine at P4, broad at P3, proline > alanine at P2, and leucine > norleucine > methionine at P1. The enzyme activity was found to be highly dependent on the length and sequence of substrates, indicative of a regulatory function for human granzyme M. Finally, the interaction between granzyme M and the serpins {alpha}1-antichymotrypsin, {alpha}1 -proteinase inhibitor, and proteinase inhibitor 9 was characterized by using a candidate-based approach to identify potential endogenous inhibitors. Proteinase inhibitor 9 was effectively hydrolyzed and inactivated by human granzyme M, raising the possibility that this orphan granzyme bypasses proteinase inhibitor 9 inhibition of granzyme B.


Received for publication, October 8, 2004 , and in revised form, October 18, 2004.

* This work was supported in part by National Institutes of Health Grant CA 72006. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

|| To whom correspondence should be addressed. Tel.: 415-476-8146; Fax: 415-502-8298; E-mail: craik{at}cgl.ucsf.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
L. Wu, L. Wang, G. Hua, K. Liu, X. Yang, Y. Zhai, M. Bartlam, F. Sun, and Z. Fan
Structural Basis for Proteolytic Specificity of the Human Apoptosis-Inducing Granzyme M
J. Immunol., July 1, 2009; 183(1): 421 - 429.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. P. Cullen, I. S. Afonina, R. Donadini, A. U. Luthi, J. P. Medema, P. I. Bird, and S. J. Martin
Nucleophosmin Is Cleaved and Inactivated by the Cytotoxic Granule Protease Granzyme M during Natural Killer Cell-mediated Killing
J. Biol. Chem., February 20, 2009; 284(8): 5137 - 5147.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. Bovenschen, P. J. A. de Koning, R. Quadir, R. Broekhuizen, J. M. A. Damen, C. J. Froelich, M. Slijper, and J. A. Kummer
NK Cell Protease Granzyme M Targets {alpha}-Tubulin and Disorganizes the Microtubule Network
J. Immunol., June 15, 2008; 180(12): 8184 - 8191.
[Abstract] [Full Text] [PDF]


Home page
Brief Funct Genomic ProteomicHome page
G. B. Scott, J. L. Meade, and G. P. Cook
Profiling killers; unravelling the pathways of human natural killer cell function
Brief Funct Genomic Proteomic, January 21, 2008; (2008) elm037v1.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. Bossard, K. Belhadj, F. Reyes, N. Martin-Garcia, F. Berger, J. A. Kummer, J. Briere, A.-C. Baglin, S. Cheze, J. Bosq, et al.
Expression of the granzyme B inhibitor PI9 predicts outcome in nasal NK/T-cell lymphoma: results of a Western series of 48 patients treated with first-line polychemotherapy within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials
Blood, March 1, 2007; 109(5): 2183 - 2189.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. Godal, U. Keilholz, L. Uharek, A. Letsch, A. M. Asemissen, A. Busse, I.-K. Na, E. Thiel, and C. Scheibenbogen
Lymphomas are sensitive to perforin-dependent cytotoxic pathways despite expression of PI-9 and overexpression of bcl-2
Blood, April 15, 2006; 107(8): 3205 - 3211.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Adrain, P. J. Duriez, G. Brumatti, P. Delivani, and S. J. Martin
The Cytotoxic Lymphocyte Protease, Granzyme B, Targets the Cytoskeleton and Perturbs Microtubule Polymerization Dynamics
J. Biol. Chem., March 24, 2006; 281(12): 8118 - 8125.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
B. Bade, H. E. Boettcher, J. Lohrmann, C. Hink-Schauer, K. Bratke, D. E. Jenne, J. C. Virchow Jr, and W. Luttmann
Differential expression of the granzymes A, K and M and perforin in human peripheral blood lymphocytes
Int. Immunol., November 1, 2005; 17(11): 1419 - 1428.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. I. Pao, N. Sumaria, J. M. Kelly, S. v. Dommelen, E. Cretney, M. E. Wallace, D. A. Anthony, A. P. Uldrich, D. I. Godfrey, J. M. Papadimitriou, et al.
Functional Analysis of Granzyme M and Its Role in Immunity to Infection
J. Immunol., September 1, 2005; 175(5): 3235 - 3243.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement